Skip to main navigation
CervoMed
  • Investors Overview
  • News & Events
    News Releases Events and Presentations
  • Corporate Governance
    Governance Overview Management Team Board of Directors Committee Composition
  • Financial Information
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Shareholder Services
    Investor FAQs Email Alerts IR Contacts

Event Details

CervoMed Results from Week 32 of the Phase 2b RewinD-LB Study

Jul 28, 2025 8:00 AM EDT

Webcast

Supporting Materials

RewinD-LB Week 32 Extension Results Presentation 1.3 MB

Contact Investor Relations

Argot Partners
cervomed@argotpartners.com
212-600-1902
Investors@cervomed.com
 

  • Terms of Use
  • Privacy
  • © CervoMed 2026